QuidelOrtho Corporation QDEL

Company Overview

QuidelOrtho Corporation is a U.S.-based diagnostics company focused on developing, manufacturing, and commercializing diagnostic testing technologies used in hospitals, clinical laboratories, physician offices, retail settings, and point-of-care environments. The company operates within the in vitro diagnostics industry and serves healthcare providers, laboratories, public health agencies, and blood and plasma screening organizations. QuidelOrtho was formed through the combination of Quidel Corporation and Ortho Clinical Diagnostics, creating a broader diagnostics platform spanning rapid diagnostics, immunohematology, clinical chemistry, molecular diagnostics, and transfusion medicine.

The company’s primary revenue drivers include its Labs, Transfusion Medicine, and Point of Care business segments, with recurring revenue generated from consumables, reagents, testing cartridges, and instrument placements. QuidelOrtho maintains a competitive position through its installed instrument base, long-standing hospital and laboratory relationships, and broad menu of diagnostic assays. Historically, Quidel expanded through rapid infectious disease testing and molecular diagnostics, while Ortho Clinical Diagnostics contributed a large global laboratory diagnostics franchise and transfusion medicine business. The merger materially expanded the company’s international scale and product breadth.